Martin Shkreli’s Latest Plan to Sharply Raise Drug Price Prompts Outcry

http://rss.nytimes.com/c/34625/f/640350/s/4c2d91a5/sc/19/l/0L0Snytimes0N0C20A150C120C120Cbusiness0Cmartin0Eshkrelis0Elatest0Eplan0Eto0Esharply0Eraise0Edrug0Eprice0Eprompts0Eoutcry0Bhtml0Dpartner0Frss0Gemc0Frss/story01.htm

Critics say that Turing, the pharmaceutical led by Mr. Shkreli, is exploiting a program that awards vouchers that can be sold at huge profits while pricing drugs out of patients’ reach.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s